发明名称 |
The use of phytocannabinoids in the treatment of ovarian carcinoma |
摘要 |
The present invention relates to the use of phytocannabinoids in the treatment of ovarian cancer. Preferably the phytocannabinoid is selected from the group consisting of: cannabidiol (CBD); cannabidiol acid (CBDA); cannabigerol (CBG); cannabigerolic acid (CBGA); cannabigerol propyl variant (CBGV); and tetrahydrocannabivarin (THCV). In a further embodiment the one or more phytocannabinoids are used in combination with each other. Preferably the combination of cannabinoids consists of CBD and CBG. |
申请公布号 |
GB2516335(B) |
申请公布日期 |
2017.02.08 |
申请号 |
GB20140006473 |
申请日期 |
2014.04.10 |
申请人 |
GW Pharma Limited |
发明人 |
Farideh Javid;Marnie Duncan;Colin Stott |
分类号 |
A61K36/185;A61K31/05;A61K31/352;A61P35/00 |
主分类号 |
A61K36/185 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|